CDG Médical: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CDG Médical
Largest movements
- Cash +€43,740
up €43,740 (+25.8%), from €169,527 to €213,267
mainly Net result for the year (+€76,312) and Depreciation (+€3,253)
- Receivables within one year +€15,898
up €15,898 (+329%), from €4,837 to €20,735
of which Other amounts receivable: +€16,135
- Profit (loss) carried forward +€75,479
up €75,479 (+53.8%), from €140,283 to €215,762
- Other debts -€10,103
down €10,103 (-97.6%), from €10,353 to €250
- Tax, wage and social debts -€5,459
down €5,459 (-20.9%), from €26,169 to €20,710
- Gross operating margin -€25,976
down €25,976 (-20.2%), from €128,349 to €102,373
- Taxes -€3,193
down €3,193 (-12.7%), from €25,196 to €22,003
- Depreciation -€1,747
down €1,747 (-34.9%), from €5,000 to €3,253
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €180,054 | €238,709 | +€58,656 | +32.6% |
| Fixed assets | 21/28 | €2,795 | €1,130 | -€1,664 | -59.6% |
| Tangible fixed assets | 22/27 | €2,795 | €1,130 | -€1,664 | -59.6% |
| Furniture and vehicles | 24 | €2,795 | €1,130 | -€1,664 | -59.6% |
| Current assets | 29/58 | €177,259 | €237,579 | +€60,320 | +34.0% |
| Amounts receivable within one year | 40/41 | €4,837 | €20,735 | +€15,898 | +329% |
| Trade receivables | 40 | €4,837 | €4,600 | -€237 | -4.9% |
| Other amounts receivable | 41 | - | €16,135 | +€16,135 | |
| Cash at bank and in hand | 54/58 | €169,527 | €213,267 | +€43,740 | +25.8% |
| Deferred charges and accrued income | 490/1 | €2,895 | €3,577 | +€682 | +23.6% |
| Total equity and liabilities | 10/49 | €180,054 | €238,709 | +€58,656 | +32.6% |
| Equity | 10/15 | €141,283 | €216,762 | +€75,479 | +53.4% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €140,283 | €215,762 | +€75,479 | +53.8% |
| Amounts payable | 17/49 | €38,771 | €21,947 | -€16,824 | -43.4% |
| Amounts payable within one year | 42/48 | €38,771 | €21,947 | -€16,824 | -43.4% |
| Trade debts | 44 | €2,249 | €987 | -€1,262 | -56.1% |
| Suppliers | 440/4 | €2,249 | €987 | -€1,262 | -56.1% |
| Taxes, remuneration and social security | 45 | €26,169 | €20,710 | -€5,459 | -20.9% |
| Taxes | 450/3 | €26,169 | €20,710 | -€5,459 | -20.9% |
| Other amounts payable | 47/48 | €10,353 | €250 | -€10,103 | -97.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,000 | €3,253 | -€1,747 | -34.9% |
| Other operating charges | 640/8 | €802 | €638 | -€164 | -20.4% |
| Gross operating margin | 9900 | €128,349 | €102,373 | -€25,976 | -20.2% |
| Operating profit (loss) | 9901 | €122,547 | €98,482 | -€24,066 | -19.6% |
| Financial income | 75/76B | €3 | - | -€3 | |
| Recurring financial income | 75 | €3 | - | -€3 | |
| Financial charges | 65/66B | €61 | €167 | +€106 | +174% |
| Recurring financial charges | 65 | €61 | €167 | +€106 | +174% |
| Profit (loss) for the period before taxes | 9903 | €122,490 | €98,315 | -€24,175 | -19.7% |
| Income taxes | 67/77 | €25,196 | €22,003 | -€3,193 | -12.7% |
| Profit (loss) for the period | 9904 | €97,293 | €76,312 | -€20,981 | -21.6% |
| Profit (loss) for the period to be appropriated | 9905 | €97,293 | €76,312 | -€20,981 | -21.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.